SCHEMBL30696221

SCHEMBL30696221

CCCOCCOCCOCCOCCNCCC1c2ccccc2-c2ccccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
ALDH1A1 P00352 2/20 0.44
BCHE P06276 1/20 0.44
ACHE P22303 1/20 0.44
HTR2A P28223 4/20 0.40
HRH1 P35367 3/20 0.40
LMNA P02545 2/20 0.39
CYP2D6 P10635 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
TSHR P16473 1/20 0.38
ADRB2 P07550 2/20 0.37
RECQL P46063 1/20 0.37
HTR5A P47898 1/20 0.36
TP53 P04637 1/20 0.36
CHRM2 P08172 1/20 0.36
CYP3A4 P08684 1/20 0.36
CHRM1 P11229 1/20 0.36
DRD2 P14416 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8733839 0.81 BCHE (0.57) KDM4ESMN1; SMN2ALDH1A1BCHEACHE
SCHEMBL1703198 0.75 CA1 (0.47) BCHEACHEHTR2AKMT2AHTR5A
SCHEMBL17287169 0.74 KMT2A (0.58) SMN1; SMN2LMNAKMT2A
SCHEMBL26265400 0.74 KMT2A (0.58) SMN1; SMN2LMNAKMT2A
SCHEMBL31298664 0.74 KMT2A (0.58) SMN1; SMN2LMNAKMT2A
SCHEMBL17287173 0.74 KMT2A (0.58) SMN1; SMN2LMNAKMT2A
SCHEMBL6939847 0.72 HTR2A (0.42) KDM4ESMN1; SMN2HTR2AHRH1LMNA
SCHEMBL8715984 0.72 HTR2A (0.42) KDM4ESMN1; SMN2HTR2AHRH1LMNA
SCHEMBL1996543 0.72 HTR2A (0.54) KDM4ESMN1; SMN2BCHEACHEHTR2A
SCHEMBL20435294 0.72 CA1 (0.41) KDM4ESMN1; SMN2BCHEACHEHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117180446-A Self-assembled polypeptide coupling medicine and application thereof 国家纳米科学中心 2023-12-08 CN disclosed